Sunshine Heart Announces the Appointment of John Erb as Its Chief Executive Officer
Mar 02, 2016 21:15 pm UTC| Business
EDEN PRAIRIE, Minn., March 02, 2016 -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today the appointment of John Erb as its fulltime Chief Executive Officer (CEO) and President, effective immediately. Mr. Erb assumes...
Pilgrim's Pride to Host Annual Meeting of Shareholders on April 29, 2016
Mar 02, 2016 21:15 pm UTC| Business
GREELEY, Colo., March 02, 2016 -- Pilgrim's Pride Corporation (NASDAQ:PPC) will host its annual meeting of shareholders on Friday, April 29, 2016, at 8 a.m. Mountain / 10 a.m. Eastern. This meeting, which will include a...
BERKELEY COLLEGE HOSTS QUALITY MATTERS REGIONAL CONFERENCE ON QUALITY ASSURANCE IN EDUCATION
Mar 02, 2016 21:14 pm UTC| Business
NEW YORK, March 2, 2016 -- Quality Matters (QM), a leader in quality assurance for online education, will hold its Regional Conference themed, "A Quality State of Mind," in New York City at Berkeley College on March 17...
Points International Ltd. Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 02, 2016 21:10 pm UTC| Business
- Full Year Revenue of $296.4 million, an increase of 16% year-over-year- Full Year Adjusted EBITDA of $11.1 million, an increase of 22% year-over-year- Full Year Net Income of $5.2 million, an increase of 10%...
DTS Reports Fourth Quarter and Fiscal 2015 Financial Results
Mar 02, 2016 21:05 pm UTC| Business
CALABASAS, Calif., March 02, 2016 -- DTS, Inc. (Nasdaq:DTSI), a leader in high-definition audio solutions and audio enhancement technologies, today announced financial results for the fourth quarter and fiscal year...
Skullcandy, Inc. Reports Fourth Quarter and 2015 Results
Mar 02, 2016 21:05 pm UTC| Business
PARK CITY, Utah, March 02, 2016 -- Skullcandy, Inc. (NASDAQ:SKUL), which creates world-class audio experiences through its Skullcandy® and Astro Gaming® brands, today announced financial results for the fourth quarter...
KemPharm, Inc. to Report Fourth Quarter and Year End 2015 Results
Mar 02, 2016 21:05 pm UTC| Business
CORALVILLE, Iowa, March 02, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that the Company will...